Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements

American Journal of Surgical Pathology

Volumn 22, Issue 2, 1998, Pages 188-194

  Chhieng, Cheung ^a   Cranor, Milicent ^a   Lesser, Martin E ^b   Rosen, Paul Peter ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c Memorial Hospital   (United States)

Author keywords

Breast carcinoma; Metaplastic carcinoma; Osteocartilaginous metaplasia

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER INFILTRATION; CANCER RECURRENCE; CANCER SURVIVAL; CARTILAGE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MASTECTOMY; METAPLASIA; ONCOGENE NEU; OSTEOID;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; METAPLASIA; MIDDLE AGED; OSTEOCHONDROMA;

EID: 0031940454     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199802000-00006     Document Type: Article

References (27)

1. Allen AC. So called mixed tumors of the mammary gland of dog and man, with special reference to the general problem of cartilage and bone formation. Arch Pathol Lab Med 1940;29:589.
2. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-77.
3. Costa MJ, Vogelsang J, Young LJT. p53 gene mutation in female genital tract carcinosarcomas (malignant mixed mullerian tumors): a clinicopathologic study of 74 cases. Mod Pathol 1994;7:619-27.
4. Eusebi V. Cattani MG, Ceccarelli C. Sarcomatoid carcinomas of the breast: an immunocytochemical study of 14 cases. Prog Surg Pathol 1989;10:83-99.
5. Gonzalez-Licea A, Yardley JH, Hartmann WH. Malignant tumor of the breast with bone formation. Studies by light and electron microscopy. Cancer 1967;20:1234-47.
6. Harris AL. Mutant p53: The commonest genetic abnormality human cancer? J Pathol 1990; 162:5-6.
7. Harris M, Persaud V. Carcinosarcoma of the breast. J Pathol 1974; 112:99-105.
8. Huvos AG, Lucas JC Jr, Foote FW. Metaplastic breast carcinoma. NY State J Med 1973;73:1078-82.
9. Kahn LB, Uys CJ, Dale J, Rutherford S. Carcinoma of the breast with metaplasia to chondrosarcoma: a light and electron microscopic study. Histopathology 1978;2:93-106.
10. Kaufman MW. Marti JR, Gallager HS, Hoehn JL. Carcinoma of the breast with pseudosarcomatous metaplasia. Cancer 1984;53: 1908-17.
11. Klijn JGM, Look MP, Portengen H, Alexieva-Figusch J, van Putten WLJ, Foekens JA. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study. Breast Cancer Res Treat 1994;29:73- 83.
12. Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz MK. Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology. Cancer 1981;48:299-309.
13. Mayall FG, Rutty K, Campbell F, Goddard H. p53 immunostaining suggest that uterine carcinosarcomas are monoclonal. Histopathology 1994;24:211-4.
14. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 1987;11:918-29.
15. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors. Am J Pathol 1992; 140:145-53.
16. Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L. Immunohistochemical detection of HER2/neu in node-negative breast carcinoma: a study of epidemiologic risk factors, histologic features and prognosis. Cancer 1995;75:1320-6.
17. Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors. J Clin Oncol 1995;13:821-30.
18. Rosen PP, Oberman HA. Tumors of the Mammary Gland, 3rd series. Fascicle 7. Washington, DC: American Registry of Pathology AFIP 1993.
19. Rottino A, Wilson K. Osseous, cartilaginous and mixed tumors of the human breast. A review of the literature. Arch Surg 1945;50: 184.
20. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells associated with brain tumor progression. Nature 1992;355:846-7.
21. Smith BH, Taylor HB. The occurrence of bone and cartilage in mammary tumors. Am J Clin Pathol 1969;51:610.
22. Soini Y, Vahakangas K, Nuorva K, Kamel D, Lane DP, Paako. p53 immunostaining in malignant fibrous histiocytomas and other mesenchymal tumors. J Pathol 1992;168:29-33.
23. Wargotz ES, Morris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 1989;20:628-35.
24. Wargotz ES, Morris HJ. Metaplastic carcinomas of the breast. II. Carcinosarcoma. Cancer 1989;64:1490-9.
25. Weidner N. Sarcomatoid carcinoma of the breast. Am J Surg Pathol 1987:351-8.
26. World Health Organization. Histological Typing of Breast Tumors, 2nd ed. International Histological Classification of Tumours. No. 2. Geneva: World Health Organization, 1981:19.
27. Wynford-Thomas D. Oncogenes and anti-oncogenes: the molecular basis of tumor behavior. J Pathol 1991;165:187-201.